er logo points to home page Home page Search Glossary Search Links Database Sitemap Contact Expert Reviews in Molecular Medicine
Reprint version of article Features associated with the article       Register interest

Expert Reviews in Molecular Medicine: http://www.expertreviews.org/
Accession information: Vol. 8; Issue 11; 24 May 2006 Abstract
PDF

Genetic factors in amyotrophic lateral sclerosis

Emily F. Goodall and Karen E. Morrison

Author contact details

Table 2. Genetic factors in amyotrophic lateral sclerosisa
Disease Locus Gene Inheritance Onset Features Refs
ALS1 21q22.21 SOD1 AD/AR Adult and juvenile ALS phenotype; varies depending on mutation 6
ALS2 2q33 Alsin AR Juvenile

ALS and PLS; slow progression

15
ALS3 18q21 Unknown AD Adult

ALS phenotype

145
ALS4 9q34 Senataxin AD Juvenile

Slow progression

18
ALS5 15q15.1-q21.1 Unknown AR Juvenile No pseudobulbar signs; slow progression 146
ALS6 16q12 Unknown AD Adult Short duration 147, 148
ALS7 20ptel Unknown AD Adult Short duration 148
ALS8 20q13.33 VAPB AD Adult

Slow progression

149
ALS—FTD 9q21-22 Unknown AD Adult

ALS with fronto- temporal dementia

150
ALS with Parkinsonism and dementia 17q21 MAPT AD Adult

ALS disorder with Parkinsonism and dementia

151
Progressive lower MND 2q13 DCTN1 AD Adult

Lower motor neuron disorder

78
Sporadic ALS 6q12 VEGF Risk factor  

ALS

22

22q12.1-q13.1

Neurofilament heavy chain Risk factor   ALS 19, 20, 21

MtDNA

Deletions Risk factor   ALS 23, 24

6q21.3

HFE Risk factor   ALS 25

14q11.2

Angiogenin Risk factor   ALS 26, 27
19q13.2 ApoE (e4) Risk factor   ALS 152

a Loci for mendelian forms of ALS are listed followed by genes in which polymorphisms have been identified as risk factors in sporadic ALS.
Abbreviations: AD, autosomal dominant; ALS, amyotrophic lateral sclerosis; ApoE; apolipoprotein E; AR, autosomal recessive; DCTN1, dynactin p150 subunit; FTD, fronto-temporal dementia; HFE, haemochromatosis gene (involved in iron metabolism); MAPT, microtubule-associated protein Tau; MND, motor neuron disease; MtDNA, mitochondrial DNA; PLS, primary lateral sclerosis; SOD1, superoxide dismutase 1; VAPB, vesicle-associated membrane protein; VEGF, vascular endothelial growth factor.


References cited in Table 2

6 Rosen, D.R. et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62, PubMed

15 Yang, Y. et al. (2001) The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet 29, 160-165, PubMed

18 Chen, Y.Z. et al. (2004) DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet 74, 1128-1135, PubMed

19 Figlewicz, D.A. et al. (1994) Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum Mol Genet 3, 1757-1761, PubMed

20 Tomkins, J. et al. (1998) Novel insertion in the KSP region of the neurofilament heavy gene in amyotrophic lateral sclerosis (ALS). Neuroreport 9, 3967-3970, PubMed

21 Al-Chalabi, A. et al. (1999) Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum Mol Genet 8, 157-164, PubMed

22 Lambrechts, D. et al. (2003) VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 34, 383-394, PubMed

23 Dhaliwal, G.K. and Grewal, R.P. (2000) Mitochondrial DNA deletion mutation levels are elevated in ALS brains. Neuroreport 11, 2507-2509, PubMed

24 Vielhaber, S. et al. (2000) Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis. Brain 123 ( Pt 7), 1339-1348, PubMed

25 Goodall, E.F. et al. (2005) Association of the H63D polymorphism in the hemochromatosis gene with sporadic ALS. Neurology 65, 934-937, PubMed

26 Greenway, M.J. et al. (2004) A novel candidate region for ALS on chromosome 14q11.2. Neurology 63, 1936-1938, PubMed

27 Greenway, M.J. et al. (2006) ANG mutations segregate with familial and ‘sporadic’ amyotrophic lateral sclerosis. Nat Genet 38, 411-413, PubMed

78 Puls, I. et al. (2003) Mutant dynactin in motor neuron disease. Nat Genet 33, 455-456, PubMed

145 Hand, C.K. et al. (2002) A novel locus for familial amyotrophic lateral sclerosis, on chromosome 18q. Am J Hum Genet 70, 251-256, PubMed

146 Hentati, A. et al. (1998) Linkage of a commoner form of recessive amyotrophic lateral sclerosis to chromosome 15q15-q22 markers. Neurogenetics 2, 55-60, PubMed

147 Abalkhail, H. et al. (2003) A new familial amyotrophic lateral sclerosis locus on chromosome 16q12.1-16q12.2. Am J Hum Genet 73, 383-389, PubMed

148 Sapp, P.C. et al. (2003) Identification of two novel loci for dominantly inherited familial amyotrophic lateral sclerosis. Am J Hum Genet 73, 397-403, PubMed

149 Nishimura, A.L. et al. (2004) A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am J Hum Genet 75, 822-831, PubMed

150 Hosler, B.A. et al. (2000) Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22. Jama 284, 1664-1669, PubMed

151 Hutton, M. et al. (1998) Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702-705, PubMed

152 Drory, V.E. et al. (2001) Association of APOE epsilon4 allele with survival in amyotrophic lateral sclerosis. J Neurol Sci 190, 17-20, PubMed

| home | search | glossary | links | sitemap | contact |

Expert Reviews in Molecular Medicine © Cambridge University Press ISSN 1462-3994 (Disclaimer and copyright)
Editorial Office: Centre for Applied Research in Educational Technologies (CARET), 1st Floor, 16 Mill Lane, Cambridge, CB2 1SB, UK. Tel: +44 (0)1223 765 375; Fax: +44(0)1223 765 505; E-mail: ermm@caret.cam.ac.uk